Announced
Financials
Sources
Tags
Pharmaceuticals
Acquisition
Public
Single Bidder
China
pharmaceutical company
Pending
Private Equity
Minority
Friendly
Synopsis
Private equity firm Hillhouse Capital Management agreed to acquire a 7.5% stake in Asymchem, a Chinese pharmaceutical company, for $331m. After the deal is complete, Hillhouse will help facilitate deals between Asymchem and the innovative drug firms in which the new investor already invests or will invest in.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.